|
|
||||||||
The Journal of Immunology, Vol 157, Issue 2 874-883, Copyright © 1996 by American Association of Immunologists
ARTICLES |
JC Mason, H Yarwood, A Tarnok, K Sugars, AA Harrison, PJ Robinson and DO Haskard
Department of Medicine, MRC Clinical Sciences Centre, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom.
Thy-1 is a glycosylphosphatidylinositol-anchored member of the Ig superfamily whose function, particularly in the human, remains unknown. We have demonstrated that human Thy-1 is expressed on endothelial cells (EC) both in situ and on the surface of cultured human umbilical vein EC and dermal microvascular EC (DMEC). The expression of the molecule decreased with serial passage but was restored by treatment of EC with PMA and phorbol-12,13-dibutyrate (PBu), which increased Thy-1 by up to 100-fold in a dose-dependent manner. This increase was first detectable at 12 h post-stimulation, peaked at 48 h, and was maintained at 72 h. In PBu-stimulated DMEC, Western blotting revealed Thy-1 to be a 29-kDa molecule, while Northern analysis demonstrated an increase in steady- state Thy-1 mRNA. Thy-1 expression was also induced on DMEC by treatment with TNF. Inhibition studies showed that the induction of Thy- 1 by PBu and TNF was protein synthesis dependent. The up-regulation of Thy-1 by PBu, but not TNF, was inhibited by the protein kinase C inhibitor RO31-8220, suggesting the presence of protein kinase C- dependent and -independent pathways for Thy-1 expression. To investigate the function of Thy-1 on human EC, we studied changes in intracellular calcium concentration ([Ca2+]i) following cross-linking of Thy-1 on human umbilical vein EC. This resulted in a rapid transient rise of [Ca2+]i in EC. Our results demonstrate for the first time the presence of Thy-1 on cultured human EC. The expression on EC, the inducibility by TNF, and the ability to transmit signals suggest that Thy-1 may have an important role in inflammatory responses.
This article has been cited by other articles:
![]() |
P. H. Tan, S.-A. Xue, M. Manunta, S. C. Beutelspacher, H. Fazekasova, A.K.M. Shamsul Alam, M. O. McClure, and A. J.T. George Effect of Vectors on Human Endothelial Cell Signal Transduction: Implications for Cardiovascular Gene Therapy Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 462 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nadra, J. C. Mason, P. Philippidis, O. Florey, C. D.W. Smythe, G. M. McCarthy, R. C. Landis, and D. O. Haskard Proinflammatory Activation of Macrophages by Basic Calcium Phosphate Crystals via Protein Kinase C and MAP Kinase Pathways: A Vicious Cycle of Inflammation and Arterial Calcification? Circ. Res., June 24, 2005; 96(12): 1248 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. M. Haeryfar and D. W. Hoskin Thy-1: More than a Mouse Pan-T Cell Marker J. Immunol., September 15, 2004; 173(6): 3581 - 3588. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wetzel, T. Chavakis, K. T. Preissner, M. Sticherling, U.-F. Haustein, U. Anderegg, and A. Saalbach Human Thy-1 (CD90) on Activated Endothelial Cells Is a Counterreceptor for the Leukocyte Integrin Mac-1 (CD11b/CD18) J. Immunol., March 15, 2004; 172(6): 3850 - 3859. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Mason, Z. Ahmed, R. Mankoff, E. A. Lidington, S. Ahmad, V. Bhatia, A. Kinderlerer, A. M. Randi, and D. O. Haskard Statin-Induced Expression of Decay-Accelerating Factor Protects Vascular Endothelium Against Complement-Mediated Injury Circ. Res., October 18, 2002; 91(8): 696 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Lidington, D. O. Haskard, and J. C. Mason Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury Blood, October 15, 2000; 96(8): 2784 - 2792. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yarwood, J. C. Mason, D. Mahiouz, K. Sugars, and D. O. Haskard Resting and activated T cells induce expression of E-selectin and VCAM-1 by vascular endothelial cells through a contact-dependent but CD40 ligand-independent mechanism J. Leukoc. Biol., August 1, 2000; 68(2): 233 - 242. [Abstract] [Full Text] |
||||
![]() |
M. G. JACOBS, P. J. ROBINSON, C. BLETCHLY, J. M. MACKENZIE, and P. R. YOUNG Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction FASEB J, August 1, 2000; 14(11): 1603 - 1610. [Abstract] [Full Text] |
||||
![]() |
H Sheikh, H Yarwood, A Ashworth, and C. Isacke Endo180, an endocytic recycling glycoprotein related to the macrophage mannose receptor is expressed on fibroblasts, endothelial cells and macrophages and functions as a lectin receptor J. Cell Sci., January 3, 2000; 113(6): 1021 - 1032. [Abstract] [PDF] |
||||
![]() |
J. C. Mason, H. Yarwood, K. Sugars, B. P. Morgan, K. A. Davies, and D. O. Haskard Induction of Decay-Accelerating Factor by Cytokines or the Membrane-Attack Complex Protects Vascular Endothelial Cells Against Complement Deposition Blood, September 1, 1999; 94(5): 1673 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-S. Lee, M. K. Jain, B. M. Arkonac, D. Zhang, S.-Y. Shaw, S. Kashiki, K. Maemura, S.-L. Lee, N. K. Hollenberg, M.-E. Lee, et al. Thy-1, a Novel Marker for Angiogenesis Upregulated by Inflammatory Cytokines Circ. Res., May 4, 1998; 82(8): 845 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Risau Angiogenesis Is Coming of Age Circ. Res., May 4, 1998; 82(8): 926 - 928. [Full Text] [PDF] |
||||
![]() |
J. C. Mason, E. A. Lidington, S. R. Ahmad, and D. O. Haskard bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction Am J Physiol Cell Physiol, March 1, 2002; 282(3): C578 - C587. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |